While the Apollo Program of the 1960s is best known for being the first time a human set foot on an alien surface, the original moonshot had a more direct, albeit lesser-known, impact on our daily lives. A slew of core technologies had to be established or upgraded for the Apollo missions to take place. Without the rallying cry of the space race, communications satellites, GPS, and microchips could not have grown as quickly, if at all.
The microprocessor business is now worth half a trillion dollars. A chip shortage must be already halting everything from automobiles to washing machines. Serial entrepreneur Ben Lamm is attempting to construct his version of a moonshot with a new firm called Colossal, which wants to re-create and rewild the woolly mammoth alongside gene-editing pioneer and Harvard professor George Church.
Colossal is very confident that there will be some pretty interesting breakthroughs in the world of genomics, multiplex editing, and in software databases for genetic reconciliation.”According to Grand View Research, the global biotech business is presently worth $753 billion and is expected to expand to over $2 trillion by 2028. Even snagging a little piece of such a vast business would help Colossal survive. However, Lamm told us that the $15 million initial round it garnered from 12 investors.